Regulatory Update: RFK Jr. announced Feb 2026 — 14 peptides expected to return to legal compounding status. Reclassification pending. Learn more

← Back to Peptide Guides
Peptide Profiles: What Buyers Need To Know3 min read

Thymosin Alpha-1 (Ta1)

Thymosin Alpha-1 is an immune-modulating peptide with decades of clinical use outside the US. Here's what buyers need to know.

What Is Thymosin Alpha-1?

Thymosin Alpha-1 (Ta1) is a 28-amino-acid peptide naturally produced by the thymus gland. It plays a central role in immune system modulation, particularly in T-cell maturation and function. Ta1 is approved as a pharmaceutical drug in over 35 countries (marketed as Zadaxin), primarily for hepatitis B and C treatment and as an immune adjuvant — but it has never been FDA-approved in the United States.

Thymosin Alpha-1 is one of the most clinically validated peptides in the reclassification pipeline — it has real Phase III trial data and decades of clinical use in Asia, Europe, and Latin America.


Quick Facts

PropertyDetail
Amino Acids28
Molecular Weight~3,108 Da
OriginThymus gland extract (synthetic for commercial use)
Regulatory StatusExpected Category 1 reclassification
Prescription RequiredYes (pharmacy); No (research vendor)
Approved Outside USYes — 35+ countries as Zadaxin

Research Areas of Interest

  • Immune modulation — enhances T-cell function, dendritic cell maturation, and natural killer cell activity
  • Chronic viral infections — studied extensively for hepatitis B and C; approved for this use in multiple countries
  • Cancer immunotherapy adjunct — investigated as a complement to chemotherapy and immunotherapy regimens
  • Vaccine enhancement — research suggests it may improve antibody response in immunocompromised individuals
  • Sepsis and critical illness — emerging research on outcomes in critically ill patients

How It's Sold

SourceFormPrescription?Typical Cost
Research VendorsLyophilized powder (5mg vial)No$40-90/vial
Compounding PharmacyInjectable (subcutaneous)Yes$150-400+/month

What to Look For on the COA

  • HPLC purity — minimum 95% research grade, 98%+ preferred
  • Mass spectrometry — confirmed molecular weight of ~3,108 Da
  • Endotoxin testing — critical for injectable use
  • Amino acid analysis — confirms full 28-amino-acid sequence
  • Batch/lot number — must match product label

Ta1 is a larger peptide (28 amino acids) than many popular compounds, making synthesis more complex and quality more variable. Third-party testing is especially important.


Storage Guide

  • Lyophilized (powder): Store at -20°C for long-term stability; 2-8°C for short-term
  • Reconstituted: Refrigerate at 2-8°C. Use within 14-21 days
  • All forms: Protect from light. Avoid repeated freeze/thaw cycles

Key Sourcing Tips

  1. Always request and verify the COA — batch numbers must match your product label
  2. Ta1 is a longer peptide (28aa), making it more expensive to synthesize correctly — be skeptical of unusually cheap sources
  3. Compare purity and mass spec data across vendors before purchasing
  4. For personal use: work with a licensed provider and compounding pharmacy
  5. Avoid any source making specific disease treatment claims — Ta1 is not FDA-approved in the US

Prescription peptide access is coming

Join the waitlist to be notified when legal peptide access through licensed providers launches.

Learn more about what's coming →